These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8562191)

  • 21. Treatment with colchicine and survival of patients with ascitic cirrhosis: a double-blind randomized trial.
    Adhami JE; Basho J
    Panminerva Med; 1998 Mar; 40(1):75-81. PubMed ID: 9573762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
    Das A
    Am J Gastroenterol; 1998 Oct; 93(10):1895-900. PubMed ID: 9772051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evolution and prognosis in patients with liver cirrhosis. II. A multifactorial analysis using a stepped regression mathematical model].
    Chernev K; Isa S; Bakalov V; Aleksiev Ch
    Vutr Boles; 1990; 29(5):53-8. PubMed ID: 2080613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propranolol in the treatment of cirrhotic ascites.
    Rector WG; Reynolds TB
    Arch Intern Med; 1984 Sep; 144(9):1761-3. PubMed ID: 6476994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of ascites in liver cirrhosis].
    Geller LI
    Sov Med; 1991; (5):46-7. PubMed ID: 1876922
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bumetanide therapy of cirrhotic ascites. Comparison of different doses and modes of administration].
    Saffiotti O; Balzano A; Rinaldi M; Savarese M; Sito M; Del Vecchio-Blanco C
    Clin Ter; 1983 May; 105(4):281-8. PubMed ID: 6872470
    [No Abstract]   [Full Text] [Related]  

  • 30. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
    Buligescu L; Candiori R
    Med Interna (Bucur); 1970 May; 22(5):573-92. PubMed ID: 5426383
    [No Abstract]   [Full Text] [Related]  

  • 31. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ascites complicating cirrhosis].
    Valla DC
    Rev Prat; 1997 Mar; 47(5):491-6. PubMed ID: 9138410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of diuretics from the functional viewpoint. 7. Treatment of edema. (2). Treatment of edema and ascites caused by heart failure or liver cirrhosis].
    Furukawa T
    Saishin Igaku; 1965 Jul; 20(7):1743-58. PubMed ID: 5884753
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of serum creatinine and prognostic scoring systems in assessing hospital mortality in critically ill cirrhotic patients with upper gastrointestinal bleeding.
    Chen YC; Tsai MH; Hsu CW; Ho YP; Lien JM; Chang MY; Fang JT; Huang CC; Chen PC
    J Nephrol; 2003; 16(4):558-65. PubMed ID: 14696759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascites formation and dynamics in cirrhotic patients.
    Gentilini P
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):749-51. PubMed ID: 7496863
    [No Abstract]   [Full Text] [Related]  

  • 37. [Present status of the treatment of ascites in liver cirrhosis].
    Sepúlveda B; Perches A; Ramírez C
    Gac Med Mex; 1968 Feb; 98(2):206-14. PubMed ID: 5738270
    [No Abstract]   [Full Text] [Related]  

  • 38. [New diuretic with anti-kaliuretic effect in the treatment of cirrhotic ascitis: MK 870(amyloid hydrochlorate). Clinico-humoral study].
    Schmukler B; Bisio S; Iovine E; Cervini BA
    Prensa Med Argent; 1968 Sep; 55(30):1442-6. PubMed ID: 5708468
    [No Abstract]   [Full Text] [Related]  

  • 39. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
    Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
    Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
    Moore KP; Wong F; Gines P; Bernardi M; Ochs A; Salerno F; Angeli P; Porayko M; Moreau R; Garcia-Tsao G; Jimenez W; Planas R; Arroyo V
    Hepatology; 2003 Jul; 38(1):258-66. PubMed ID: 12830009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.